Source document: https://docs-lawep.s3.us-east-2.amazonaws.com/1697636554244.pdf (Australia)
Committee Secretariat PO Box 6021 Parliament House CANBERRA Canberra ACT 2600 Inquiry into Sleep Health Awareness in Australia Dear Sir/ Madam I am the founder and Chief Technology Officer for Oventus Medical – an early stage ASX listed company with innovative products treating people with snoring and obstructive sleep apnoea.
I am writing to you that regarding the Australian Parliament’s House Standing Committee on Health, Aged Care and Sport has commenced an Inquiry into Sleep Health Awareness in Australia.

Please find following our submission to the Committee relating to some of the defined terms of Reference.

1.

2.

3.

The potential and known causes, impacts and costs (economic and social) of inadequate sleep and sleep disorders on the community; a.
Not a great understanding that causes can go back to childhood and how they are orthodontically managed as well as childhood obesity.

This can cause sleep apnoea later in life Access to, support and treatment available for individuals experiencing inadequate sleep and sleep disorders, including those who are: children and adolescents, from culturally and linguistically diverse backgrounds, living in rural, regional and remote areas, Aboriginal and Torres Strait Islander; a.
Children at school need to be educated as well as their parents – especially around obstructive sleep apnoea.

Education, training and professional development available to healthcare workers in the diagnosis, treatment and management of individuals experiencing inadequate sleep and sleep disorders; a.

Needs to be formal training for dentists, GPs and sleep clinicians on the benefits of oral appliance therapy and on obstructive sleep apnoea as a disease in general.
Oventus Medical Ltd I E: reception@oventus.com.au W: www.oventus.com.au I A: 1 Swann Road Indooroopilly QLD 4068 Australia Inquiry into Sleep Health Awareness in AustraliaSubmission 87 4.

5.

Workplace awareness, practices and assistance available to those who may be impacted by inadequate sleep or sleep disorders, with a focus on: rostering practices for shift workers, heavy-work requirements, and the transport industry as compared to international best practice; and a.
Diagnosis, Testing, treatment and monitoring of obstructive sleep apnoea is inadequate.

This can affect performance in the workplace including increased number of accidents Current national research and investment into sleep health and sleeping disorders.

a. CRC-P for Personalised Treatment of Sleep Apnoea b. Australia has 3 global ASX listed companies delivering treatment – Resmed, Somnomed and Oventus.

c. Yet reimbursement from government is lower than many other western countries.
The ramifications of inadequate treatment is significant.

The flow on effects for increased cost of treatment of comorbidities (cardiovascular, diabetes, dementia, stroke etc) is orders of magnitude.

Treat early and save a lot later!


Best Regards Neil Anderson | Chief Technology Officer | Oventus Medical Ltd | |w: oventus.com.au like us discover us join us tweet us see us Oventus Medical Ltd I E: reception@oventus.com.au W: www.oventus.com.au I A: 1 Swann Road Indooroopilly, Brisbane 4068 QLD Australia Inquiry into Sleep Health Awareness in AustraliaSubmission 87